Cipla
Company Snapshot
Founded: 1935
Entity Type: Public
Employees: 30,313
Region: India
Revenue: $3,327.8 Millions
Revenue Year: 2024
Headquarter: Mumbai, India
Key Geographics: U.S., India, International
Corporate Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013 India Tel. +91-22-41916000 www.cipla.com
Company Overview
Cipla was founded in Mumbai in 1935 and released its first products in 1937. Cipla is involved in manufacturing APIs and formulation drugs, and it distributes its products in over 150 countries. Cipla started its generics business in 1999 and the unit currently offers over 150 brands and more than 11 different dosage forms across 26 therapeutic areas. The key therapeutic areas include respiratory, urology, anti-retroviral, cardiology, anti-infective, and central nervous system (CNS).
Financial Highlights (FY 2024)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
Operating Income: ***
This information is available for BCC Research members only.
Cipla In News
Company's Business Segments
- Pharmaceuticals : Develops, manufactures, sells and distributes generic or branded generic medicines as well as Active Pharmaceutical Ingredients (“API”)
- New Ventures : The operations of the Company, Consumer healthcare, Biosimilars, Speciality business
Applications/End User Industries
- Respiratory
- Asthma
- Paediatric Asthma
- COPD
- Nebulization
- HIV/AIDS
- Oncology
- Cipla Generics
- Offerings
- OTC – Cipla Health
- Cipla Diagnostics
- APIs
- Covid Care
- Pharmaceuticals
- Healthcare
BCC Research Beacon 